First‐time‐in‐human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification
Joan Perelló(Sanifit (Spain)), C. Salcedo(Sanifit (Spain)), Pieter Joubert(King's College London), Miguel D. Ferrer(Universidad de Zaragoza), Smeeta Sinha(Salford Royal NHS Foundation Trust), A. Canals(Sanifit (Spain))
Cited by 37
Related Papers
Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
|Current Medicinal Chemistry|2018|242
Acute Administration of Inorganic Nitrate Reduces V˙O2peak in Endurance Athletes
|Medicine & Science in Sports & Exercise|2011|137
Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology
|European Respiratory Journal|2011|124
Effects of L-citrulline oral supplementation on polymorphonuclear neutrophils oxidative burst and nitric oxide production after exercise
|Free Radical Research|2009|84
Antioxidant regulatory mechanisms in neutrophils and lymphocytes after intense exercise
|Journal of Sports Sciences|2008|84